SRS CAPITAL ADVISORS, INC. – Eli Lilly and Company Transaction History
SRS CAPITAL ADVISORS, INC. portfolio value:
$634,000
portfolio value
SRS CAPITAL ADVISORS, INC. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -21.76% | -545 shares | -178K | $323.35 | 1.96K |
| Q2 2022 | share | Increase | +55.11% | 890 shares | 350K | $324.23 | 2.50K |
| Q1 2022 | share | Increase | +1.13% | 18 shares | 21K | $286.37 | 1.61K |
| Q4 2021 | share | Increase | +0.19% | 3 shares | 73K | $277.25 | 1.59K |
| Q3 2021 | share | Increase | +3.04% | 47 shares | 13K | $230.3 | 1.59K |
| Q2 2021 | share | Increase | +0.98% | 15 shares | 96K | $228.04 | 1.54K |
| Q4 2020 | share | Increase | +0.26% | 4 shares | 33K | $166.32 | 1.53K |
| Q3 2020 | share | Increase | +6.93% | 99 shares | -9K | $145.05 | 1.52K |
| Q2 2020 | share | Increase | +0.28% | 4 shares | 37K | $160.1 | 1.42K |
| Q1 2020 | share | Increase | +137.90% | 826 shares | 119K | $134.64 | 1.42K |
| Q4 2019 | share | 0.00% | 0 shares | 12K | $126.91 | 599 | |
| Q3 2019 | share | 0.00% | 0 shares | 1K | $107.36 | 599 | |
| Q2 2019 | share | Increase | +2203.85% | 573 shares | 63K | $105.74 | 599 |
| Q4 2018 | share | 0.00% | 0 shares | 0 | $109.26 | 26 | |
| Q3 2018 | share | Decrease | -95.99% | -623 shares | -52K | $100.8 | 26 |
| Q2 2018 | share | Increase | +49.20% | 214 shares | 22K | $79.72 | 649 |
| Q1 2018 | share | Increase | +27.19% | 93 shares | 5K | $71.78 | 435 |
| Q4 2017 | share | Increase | +27.14% | 73 shares | 5K | $77.79 | 342 |
| Q3 2017 | share | Decrease | -66.08% | -524 shares | -42K | $78.29 | 269 |
| Q2 2017 | share | Increase | +40.11% | 227 shares | 18K | $74.85 | 793 |
| Q1 2017 | share | Increase | +163.26% | 351 shares | 31K | $76 | 566 |
| Q4 2016 | share | Increase | 0.00% | 215 shares | 16K | $66.02 | 215 |